Botulinum Toxin Type A Timing Efficacy in Patients With Synkinesis After Bell's Palsy

While FaCE, HB, and SAQ scores showed no significant differences, early BoNTA treatment within 1 year significantly improved FGS scores, indicating better outcomes. Therefore, early treatment is ideal for optimal response.

Authors

Institutions

Publication Details

Journal
Otolaryngology
Published
2025-03-07
DOI
https://doi.org/10.1002/ohn.1205
Citations
1
Primary Topic
Facial Nerve Paralysis Treatment and Research
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Botulinum Toxin Type A Timing Efficacy in Patients With Synkinesis After Bell's Palsy

Avanish Yendluri, Abdurrahman Al‐Awady, Ryan M. Sicard, Mingyang Gray et al.
1 citations
Otolaryngology
Facial Nerve Paralysis Treatment and Research
1.39
article

Botulinum Toxin Type A Timing Efficacy in Patients With Synkinesis After Bell's Palsy

Avanish Yendluri, Abdurrahman Al‐Awady, Ryan M. Sicard, Mingyang Gray, Vivek Annadata, Joshua D. Rosenberg
article en
1 citations

Abstract

While FaCE, HB, and SAQ scores showed no significant differences, early BoNTA treatment within 1 year significantly improved FGS scores, indicating better outcomes. Therefore, early treatment is ideal for optimal response.

OtolaryngologyVol. 172(6)
Icahn School of Medicine at Mount Sinai (US)
Sustainable cities and communities
Openalex Percentile: Top 23%
Facial Nerve Paralysis Treatment and Research
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.